STEGLATRO is a prescription pill that, along with diet and exercise, helps lower blood sugar levels in adults with type 2 diabetes. STEGLATRO is not for people with type 1 diabetes and/or diabetic ketoacidosis (increased ketones in your blood or urine).

STEGLATRO is for adults with type 2 diabetes, in addition to diet and exercise. Not for treating type 1 diabetes or diabetic ketoacidosis.




STEGLATRO could help significantly lower your A1C

Along with diet and exercise, STEGLATRO could help you say “so long” to some blood sugar. Even if youʼre doing what youʼre supposed to, like eating right, exercising, and taking your type 2 diabetes medication like your doctor says, A1C levels can still rise. (A1C is the average amount of sugar in your blood over the past 2 to 3 months.)

A1C Information for Type 2 Diabetes

STEGLATRO was proven to help lower blood sugar.

STEGLATRO™ (ertugliflozin) and Your Kidneys

STEGLATRO works in your kidneys to help them remove some sugar when you pee.

Learn About STEGLATRO™ (ertugliflozin) and Your Weight

Although itʼs not a weight loss medication, STEGLATRO may help you lose some weight.

Although itʼs not a weight loss medication, STEGLATRO may help you lose some weight.

In a 26-week clinical study, adults with type 2 diabetes who took STEGLATRO, along with diet and exercise, lost on average 4 pounds more than those taking placebo.

Average weight loss for people in the study:

  • STEGLATRO 5 mg: people lost an average of 6 pounds from 207 pounds at start
  • STEGLATRO 15 mg: people lost an average of 6 pounds from 200 pounds at start
  • Placebo: people lost an average of 2 pounds from 207 pounds at start

Savings on STEGLATRO™ (ertugliflozin) for Eligible, Privately Insured Patients

Not an actual coupon.

Pay as little as $0 per prescription*

Eligible, privately insured patients may pay as little as $0 per prescription on each of up to 12 qualifying prescriptions. Maximum savings is $583 per prescription.


*Not all patients are eligible. Certain restrictions apply. Please see Terms and Conditions.




TRUSTe Verified Privacy TRUSTe APEC Privacy

Copyright © 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico. US-STE-01056 04/20

Do not take STEGLATRO if you:

  • have severe kidney problems or are on dialysis
  • are allergic to ertugliflozin or any of the ingredients in STEGLATRO. Symptoms of a serious allergic reaction to STEGLATRO may include skin rash, raised red patches on your skin (hives), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking STEGLATRO and call your doctor right away.